Announcements
Trials
Browse
Landscape
Eligibility
Clinical Trials
2 trials
Recent
Start date
Enrollment
Phase 1/2
×
Active not recruiting
×
enfortumab vedotin
×
Clear all
Filters
3
NCT06483334
2026-02-18
MK-3475-04C
Merck Sharp & Dohme LLC
Phase 1/2
Active not recruiting
38 enrolled
NCT03288545
2025-11-10
EV-103
Astellas Pharma Inc
Phase 1/2
Active not recruiting
348 enrolled
1 FDA